These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9758504)

  • 21. Prevalence of genital Chlamydia in Iranian males with urethritis attending clinics in Mashhad.
    Ghanaat J; Afshari JT; Ghazvini K; Malvandi M
    East Mediterr Health J; 2008; 14(6):1333-7. PubMed ID: 19161108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Chlamydia trachomatis infection in infertile women at a university hospital in Jordan.
    Al-Ramahi M; Mahafzah A; Saleh S; Fram K
    East Mediterr Health J; 2008; 14(5):1148-54. PubMed ID: 19161088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for Chlamydia trachomatis.
    Jones R; Boag F
    BMJ; 2007 Apr; 334(7596):703-4. PubMed ID: 17413140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Universal prophylaxis for Chlamydia trachomatis and anaerobic vaginosis in women attending for suction termination of pregnancy: an audit of short-term health gains.
    Blackwell AL; Emery SJ; Thomas PD; Wareham K
    Int J STD AIDS; 1999 Aug; 10(8):508-13. PubMed ID: 10471099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlamydia trachomatis: time for screening?
    Spiliopoulou A; Lakiotis V; Vittoraki A; Zavou D; Mauri D
    Clin Microbiol Infect; 2005 Sep; 11(9):687-9. PubMed ID: 16104982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening at-risk groups for Chlamydia trachomatis.
    Practitioner; 1989 Nov; 233(1479):1518. PubMed ID: 2622831
    [No Abstract]   [Full Text] [Related]  

  • 27. Snaring a silent threat. Chlamydia declining thanks to screening and prevention.
    Hobus P
    Adv Nurse Pract; 2002 Oct; 10(10):63-6. PubMed ID: 12424886
    [No Abstract]   [Full Text] [Related]  

  • 28. Mailed urine samples are not an effective screening approach for Chlamydia trachomatis case finding among young men.
    Domeika M; Oscarsson L; Hallén A; Hjelm E; Sylvan S
    J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):789-94. PubMed ID: 17567309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contribution of a urine-based jail screening program to citywide male Chlamydia and gonorrhea case rates in New York City.
    Pathela P; Hennessy RR; Blank S; Parvez F; Franklin W; Schillinger JA
    Sex Transm Dis; 2009 Feb; 36(2 Suppl):S58-61. PubMed ID: 17989586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Towards screening for Chlamydia trachomatis].
    Kolmos HJ
    Ugeskr Laeger; 1997 Aug; 159(34):5104-5. PubMed ID: 9297316
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening young men for chlamydial infection.
    Aronson MD; Phillips RS
    JAMA; 1993 Nov; 270(17):2097-8. PubMed ID: 8411579
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chlamydia trachomatis].
    Rasmussen KL
    Ugeskr Laeger; 1996 Apr; 158(18):2560-1. PubMed ID: 8686014
    [No Abstract]   [Full Text] [Related]  

  • 33. Chlamydial infections.
    Coonrod DV
    Curr Womens Health Rep; 2002 Aug; 2(4):266-75. PubMed ID: 12150753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing asymptomatic patients for Chlamydia trachomatis.
    Br J Gen Pract; 1991 Jan; 41(342):37. PubMed ID: 2003958
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening for chlamydial infection: recommendations and rationale.
    Am Fam Physician; 2002 Feb; 65(4):673-6. PubMed ID: 11871685
    [No Abstract]   [Full Text] [Related]  

  • 36. Punching above their weight: males, reinfection, and the limited success of Chlamydia screening programs.
    Greer AL; Fisman DN
    Sex Transm Dis; 2009 Jan; 36(1):9-10. PubMed ID: 19077920
    [No Abstract]   [Full Text] [Related]  

  • 37. [Screening for asymptomatic Chlamydia trachomatis infection: cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Habets PC
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):499-501. PubMed ID: 11268916
    [No Abstract]   [Full Text] [Related]  

  • 38. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ; Bakker A; Welte R; van Bergen JE; van den Hoek JA; de Jong-van den Berg LT; Jager JC
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2350-4. PubMed ID: 11129971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN
    Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.